{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:18:32Z","timestamp":1789499912387,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is a common genetic disorder that can lead to life-threatening complications, including acute hemolytic anemia. Effective screening using advanced technology, such as point-of-care test (POCT), is critical to ensure proper clinical management, particularly in malaria-endemic areas. However, economic evidence of the quantitative POCT, such as cost structure, cost-effectiveness, and potential areas for cost savings, particularly in developing countries, including Malaysia, is scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A top\u2013down and time-driven activity-based costing was conducted at the Canselor Tuanku Muhriz Hospital, Malaysia, between February 1 and 28, 2023, for the CareStart\u2122 Biosensor S1 (CBS1) and compared with the OSMMR-2000D test, focusing on the duration to perform the screening test for G6PDd (i.e. cost per minute of turnaround time). The activities, items, and individuals involved were identified using the activity-based costing form, which includes a workflow and detailed breakdown tables. The capital cost, recurrent cost, and total expenditure for both methods were determined. Univariate sensitivity analysis was conducted by adjusting several key variables, such as human resources, disposable items, and equipment costs, by a 20% increase or decrease, and analyzing their effect on the overall cost structure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 2023, the cost of G6PDd screening using the CBS1 in Malaysia was RM47.54 (USD11.15) per test, compared with a higher cost of RM246.27 (USD54.18) per test with the OSMMR-2000D. It has been demonstrated that the major cost division for CBS1 was in the disposable item cost (58.18%), which includes the device\u2019s strips and reagents, whereas the major cost division for OSMMR-2000D was in the transportation (59.72%). The univariate sensitivity analysis revealed that the disposable item cost for CBS1 was the most sensitive parameter, which affected the total expenditure the most.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study provides valuable economic evidence on the efficiency of quantitative POCT for G6PDd. In countries with high G6PD prevalence as in Malaysia, such screening efficiency is crucial, as it would not only improve patient outcomes but also significantly reduce overall healthcare expenditures. This analysis proved that G6PDd screening using POCT is more cost-effective and time-efficient, and the method should be a policy priority for rapid, mobile, and remote screening of targeted populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045148","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:01:22Z","timestamp":1762210882000},"page":"e45148","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Economic evaluation of quantitative point-of-care testing versus spectrophotometric assay for population screening of glucose-6-phosphate dehydrogenase deficiency in Malaysia: A time-driven activity-based cost analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0768-7605","authenticated-orcid":false,"given":"Mohamed Afiq Hidayat","family":"Zailani","sequence":"first","affiliation":[{"name":"Department of Pathology, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Zahratul Azma","family":"Raja Sabudin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniza","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Community Health, Faculty of Medicine, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia"},{"name":"Faculty of Public Health, Universitas Sumatera Utara, Medan, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Baihaqi","family":"Basri","sequence":"additional","affiliation":[{"name":"Malaysian Health Technology Assessment Section, Medical Development Division, Ministry of Health Malaysia, Wilayah Persekutuan Putrajaya, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azlin","family":"Ithnin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiza","family":"Alauddin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Aishah","family":"Sulaiman","sequence":"additional","affiliation":[{"name":"UKM Medical Molecular Biology Institute (UMBI), Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainoon","family":"Othman","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science II, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia, Seremban, Negeri Sembilan, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/brv.12140","article-title":"The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.","volume":"90","author":"Stincone","year":"2015","journal-title":"Biol Rev Camb Philos Soc"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s42255-019-0043-x","article-title":"NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism.","volume":"1","author":"Chen","year":"2019","journal-title":"Nat Metab"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3390\/ijms17122069","article-title":"Glucose-6-phosphate dehydrogenase: update and analysis of new mutations around the world.","volume":"17","author":"G\u00f3mez-Manzo","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"e1003084","DOI":"10.1371\/journal.pmed.1003084","article-title":"Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: a systematic review and meta-analysis.","volume":"17","author":"Pfeffer","year":"2020","journal-title":"PLoS Med"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"17106","DOI":"10.1038\/s41598-020-74200-y","article-title":"Glucose-6-phosphate dehydrogenase deficiency in the Han Chinese population: molecular characterization and genotype-phenotype association throughout an activity distribution.","volume":"10","author":"He","year":"2020","journal-title":"Sci Rep"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"105904","DOI":"10.1016\/j.phrs.2021.105904","article-title":"The ethnogeographic variability of genetic factors underlying G6PD deficiency.","volume":"173","author":"Koromina","year":"2021","journal-title":"Pharmacol Res"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"e0294891","DOI":"10.1371\/journal.pone.0294891","article-title":"Prevalence and molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Senoi Malaysian Orang Asli population.","volume":"18","author":"Koh","year":"2023","journal-title":"PLoS One"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s10038-019-0700-7","article-title":"Genotyping of Malaysian G6PD-deficient neonates by reverse dot blot flow-through hybridisation.","volume":"65","author":"Alina","year":"2020","journal-title":"J Hum Genet"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency.","volume":"136","author":"Luzzatto","year":"2020","journal-title":"Blood"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1802537","article-title":"Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria.","volume":"380","author":"Llanos-Cuentas","year":"2019","journal-title":"N Engl J Med"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12936-017-1981-y","article-title":"Barriers to routine G6PD testing prior to treatment with primaquine.","volume":"16","author":"Ley","year":"2017","journal-title":"Malar J"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/wellcomeopenres.13373.1","article-title":"Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: a cohort study.","volume":"3","author":"Thielemans","year":"2018","journal-title":"Wellcome Open Res"},{"key":"R16-20260915","first-page":"155","article-title":"Evaluation of glucose-6-phosphate dehydrogenase stability in stored blood samples.","volume":"15","author":"Jalil","year":"2016","journal-title":"EXCLI J"},{"key":"R17-20260915","first-page":"405","article-title":"Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partially-deficient females.","volume":"34","author":"Ainoon","year":"2003","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R19-20260915","first-page":"982","article-title":"G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization.","volume":"41","author":"Azma","year":"2010","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/pathogens11111328","article-title":"Quantitative G6PD deficiency screening in routine malaria diagnostic units in the Brazilian Amazon (SAFEPRIM): an operational mixed-methods study.","volume":"11","author":"Brito-Sousa","year":"2022","journal-title":"Pathogens"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s13104-018-3964-7","article-title":"Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation.","volume":"11","author":"Alam","year":"2018","journal-title":"BMC Res Notes"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40249-021-00889-2","article-title":"Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania.","volume":"10","author":"Djigo","year":"2021","journal-title":"Infect Dis Poverty"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"e0196716","DOI":"10.1371\/journal.pone.0196716","article-title":"Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.","volume":"13","author":"Bancone","year":"2018","journal-title":"PLoS One"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"e0226927","DOI":"10.1371\/journal.pone.0226927","article-title":"Evaluation of quantitative biosensor for glucose-6-phosphate dehydrogenase activity detection.","volume":"14","author":"Pengboon","year":"2019","journal-title":"PLoS One"},{"key":"R25-20260915","first-page":"31","article-title":"Evaluation of quantitative point-of-care test for measurement of glucose-6-phosphate dehydrogenase enzyme activity in Malaysia.","volume":"45","author":"Zailani","year":"2023","journal-title":"Malays J Pathol"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s41669-020-00248-1","article-title":"Health economic evidence of point-of-care testing: a systematic review.","volume":"5","author":"Lingervelder","year":"2021","journal-title":"PharmacoEcon Open"},{"key":"R27-20260915","first-page":"131","article-title":"Time-driven activity-based costing.","volume":"82","author":"Kaplan","year":"2004","journal-title":"Harv Bus Rev"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"e015494","DOI":"10.1136\/bmjopen-2016-015494","article-title":"Does use of point-of-care testing improve cost-effectiveness of the NHS Health Check programme in the primary care setting? A cost-minimisation analysis.","volume":"7","author":"El-Osta","year":"2017","journal-title":"BMJ Open"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1016\/S2352-3018(18)30328-X","article-title":"Clinical effect and cost--effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study.","volume":"6","author":"Frank","year":"2019","journal-title":"Lancet HIV"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"e0218890","DOI":"10.1371\/journal.pone.0218890","article-title":"Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: cost-effectiveness analysis for India\u2019s public sector.","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/jmv.25479","article-title":"Impact of molecular point-of-care testing on clinical management and in-hospital costs of patients suspected of influenza or RSV infection: a modeling study.","volume":"91","author":"Rahamat-Langendoen","year":"2019","journal-title":"J Med Virol"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jinf.2022.01.034","article-title":"Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19.","volume":"84","author":"Livingstone","year":"2022","journal-title":"J Infect"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"1098828","DOI":"10.3389\/fgene.2023.1098828","article-title":"Population screening for glucose-6-phosphate dehydrogenase deficiency using quantitative point-of-care tests: a systematic review.","volume":"14","author":"Zailani","year":"2023","journal-title":"Front Genet"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"e0206331","DOI":"10.1371\/journal.pone.0206331","article-title":"Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.","volume":"13","author":"Alam","year":"2018","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:01:17Z","timestamp":1789498877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":30,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045148","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}